GGrantIndex
← Leaderboards

David F Kallmes

Mayo Clinic Rochester

Google Scholar ↗PubMed ↗ORCID ↗
$16,430,103
Attributed
$25,611,254
Total exposure
18
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,611,254 · 18

By mechanism

R01$10,140,614 · 3
R44$8,008,230 · 4
R42$2,949,208 · 1
R41$1,866,593 · 4
R21$1,517,796 · 3
R43$703,093 · 2

Top collaborators

Most similar at Mayo Clinic Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Devices”

Research focus

DevicesPatient CareAneurysmDesignEngineeringProgramsIntracranial AneurysmBaseIn VivoArteriesHemorrhageEventHemodynamicsTechnologySafetyInnovationFundingBiologicalResearch PersonnelClinical ResearchMultidisciplinarySuccessAnimal ModelMedical

Grant awards (47)

Computational and Biological Approach to Flow Diversion$398,331
R01 · FY2025 · NS
Enabling rapid and effective stroke thrombectomy procedures from a Transradial approach: Combining introducer sheath, guide catheter, and distal access catheter into a single device.$982,021
R44 · FY2024 · NS
Computational and Biological Approach to Flow Diversion$438,541
R01 · FY2024 · NS
Enabling rapid and effective stroke thrombectomy procedures from a Transradial approach: Combining introducer sheath, guide catheter, and distal access catheter into a single device.$992,721
R44 · FY2023 · NS
Computational and Biological Approach to Flow Diversion$625,074
R01 · FY2023 · NS
Two-for-one Stroke Thrombectomy: A novel Dual DAC to enhance navigability, lumen size, aspiration efficiency, and persistent flow arrest in mechanical thrombectomy$499,765
R41 · FY2023 · NS · contact PI
Harnessing the latent heat of saline evaporation for safe and effective endovascular therapeutic organ cooling$443,850
R21 · FY2023 · NS · contact PI
Computational and Biological Approach to Flow Diversion$596,768
R01 · FY2022 · NS
INvestigative Kyphoplasty Efficacy and Safety Trial (INKTEST)$239,143
R34 · FY2022 · AR · contact PI
Development of Novel Intra-aneurysmal Rapid Occlusion Device$1,499,517
R44 · FY2021 · NS
Enabling rapid and effective stroke thrombectomy procedures from a Transradial approach: Combining introducer sheath, guide catheter, and distal access catheter into a single device.$490,053
R41 · FY2021 · NS · contact PI
INvestigative Kyphoplasty Efficacy and Safety Trial (INKTEST)$186,577
R34 · FY2021 · AR · contact PI
Development of Novel Intra-aneurysmal Rapid Occlusion Device$1,499,299
R44 · FY2020 · NS
Development of a Balloon Occlusion Sheath for Stroke (BOSS)$985,384
R44 · FY2020 · NS
Simplified Transfemoral Carotid Angioplasty and Stenting Under FlowReversal Using a Novel Combination Access Sheath/Balloon System$398,081
R41 · FY2020 · HL · contact PI
Computational and Biological Approach to Flow Diversion$375,815
R01 · FY2020 · NS
Development of a Balloon Occlusion Sheath for Stroke (BOSS)$998,169
R44 · FY2019 · NS
Computational and Biological Approach to Flow Diversion$493,581
R01 · FY2019 · NS
Development of Novel Intra-aneurysmal Rapid Occlusion Device$441,740
R43 · FY2019 · NS
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms$976,739
R42 · FY2018 · NS
Development of a novel Balloon Occlusion Sheath for Stroke (BOSS)$478,694
R41 · FY2018 · NS · contact PI
Computational and Biological Approach to Flow Diversion$475,788
R01 · FY2018 · NS
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms$899,775
R42 · FY2017 · NS
Computational and Biological Approach to Flow Diversion$471,009
R01 · FY2017 · NS
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms$1,072,694
R42 · FY2016 · NS
Development of Intrasaccular Flow Disrupters for Small and Ruptured Aneurysms$1,051,119
R44 · FY2016 · NS
Computational and Biological Approach to Flow Diversion$509,078
R01 · FY2016 · NS
Translational, multimodality correlation between human and rabbit saccular aneurysms$188,826
R21 · FY2016 · NS · contact PI
Translational, multimodality correlation between human and rabbit saccular aneurysms$241,911
R21 · FY2015 · NS · contact PI
Development of a second generation intra-sacular cerebral aneurysm flow diverter$261,353
R43 · FY2011 · NS
Improved Animal Modeling of Saccular Aneurysms$487,629
R01 · FY2010 · NS · contact PI
Improved Animal Modeling of Saccular Aneurysms$525,683
R01 · FY2009 · NS · contact PI
Improved Animal Modeling of Saccular Aneurysms$528,225
R01 · FY2008 · NS · contact PI
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY$250,619
R01 · FY2008 · AR · contact PI
Improved Animal Modeling of Saccular Aneurysms$596,652
R01 · FY2007 · NS · contact PI
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY$1
R01 · FY2007 · AR · contact PI
Improved Animal Modeling of Saccular Aneurysms$629,301
R01 · FY2006 · NS · contact PI
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY$392,334
R01 · FY2005 · AR
Improved Animal Modeling of Saccular Aneurysms$453,842
R01 · FY2004 · NS
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY$380,292
R01 · FY2004 · AR
Genetic and Tissue Engineering for Aneurysms$209,709
R21 · FY2004 · HL
Improved Animal Modeling of Saccular Aneurysms$485,119
R01 · FY2003 · NS
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY$411,660
R01 · FY2003 · AR
Genetic and Tissue Engineering for Aneurysms$216,750
R21 · FY2003 · HL
SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTY$403,353
R01 · FY2002 · AR
Genetic and Tissue Engineering for Aneurysms$216,750
R21 · FY2002 · HL
Improved Animal Modeling of Saccular Aneurysms$211,919
R01 · FY2002 · NS